Cargando…
Intratumoral injection of PKR shRNA expressing plasmid inhibits B16-F10 melanoma growth
Autores principales: | André, Nayara Delgado, Silva, Viviane Aline Oliveira, Watanabe, Maria Angelica Ehara, De Lucca, Fernando Luiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151880/ https://www.ncbi.nlm.nih.gov/pubmed/30132553 http://dx.doi.org/10.3892/or.2018.6646 |
Ejemplares similares
-
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”
por: Xing, Hai-Bo, et al.
Publicado: (2022) -
Intratumoral Gene Electrotransfer of Plasmid DNA Encoding shRNA against Melanoma Cell Adhesion Molecule Radiosensitizes Tumors by Antivascular Effects and Activation of an Immune Response
por: Kranjc Brezar, Simona, et al.
Publicado: (2020) -
Nuclear PKR in retinal neurons in the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats
por: Silva, Viviane Aline Oliveira, et al.
Publicado: (2021) -
Construction of a lentiviral vector containing shRNA targeting ADAM17 and its role in attenuating endotoxemia in mice
por: He, Bing, et al.
Publicado: (2018) -
Corrigendum: A descriptive guide for absolute quantification of produced shRNA pseudotyped lentiviral particles by real-time PCR
por: Mournetas, Virginie, et al.
Publicado: (2019)